Epigenomics secures financing of up to EUR 5m

20-Aug-2013 - Germany

Epigenomics AG announces that it has entered into an agreement with YA Global Master SPV Ltd. through which it secured a convertible bond financing for up to EUR 5m. Under the terms of the agreement, YA Global Master SPV Ltd., over a period of up to two years, is obliged to purchase convertible notes with a total nominal amount of EUR 5m at a purchase price of 95% of the nominal amount. Epigenomics may issue the convertible notes in tranches of EUR 500,000 each at its sole discretion. A tranche comprises 500 convertible notes in the form of bearer bonds each with a nominal value of EUR 1,000 and transferrable only upon approval of Epigenomics. The convertible notes will only be issued and may only be traded in lots with a total nominal value of EUR 125,000.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

New technique for testing drugs to treat cystic fibrosis and epilepsy

Neuronal Parkinson inclusions are different than expected - Study raises new questions about the etiology of Parkinson’s disease

Neuronal Parkinson inclusions are different than expected - Study raises new questions about the etiology of Parkinson’s disease

Analytik Jena Sells Site in Eisfeld - New investor acquiring entire Optics business unit as well as component production for analytical technology

Toxic agents behind Parkinson's disease seen at work for the first time - First look at how toxic protein clusters disrupt the membranes of healthy brain cells.

Toxic agents behind Parkinson's disease seen at work for the first time - First look at how toxic protein clusters disrupt the membranes of healthy brain cells.

Ocean Optics Employee Wins Global Technology Award - Nelson Chandler takes £20K top prize from multi-national technology company

Ocean Optics Employee Wins Global Technology Award - Nelson Chandler takes £20K top prize from multi-national technology company

Measuring the magnetism of antimatter - Researchers measure antiprotons more accurately than ever before

KRÜSS is one of the innovation leaders in 2018 - TOP 100 competition success

COVID-19 : Measuring viral RNA to predict which patients will die - A statistical model uses a blood biomarker of SARS-CoV-2 to identify infected patients who are most at risk of dying of COVID-19

COVID-19 : Measuring viral RNA to predict which patients will die - A statistical model uses a blood biomarker of SARS-CoV-2 to identify infected patients who are most at risk of dying of COVID-19

Sperm navigation in 3D

Sperm navigation in 3D

Epigenomics AG Receives Allowance for Key Technology Patent in Japan - Patent broadly covers HeavyMethyl, a core technology of Epigenomics' molecular diagnostic products

Researchers cast new light on magnons to verify topological phases in magnetic materials - “Raman scattering is a standard experimental technique available in many labs, which is one of the strengths of this proposal”

Researchers cast new light on magnons to verify topological phases in magnetic materials - “Raman scattering is a standard experimental technique available in many labs, which is one of the strengths of this proposal”